Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Aethlon Medical (AEMD) over the last 15 years, with Q1 2025 value amounting to $688603.0.

  • Aethlon Medical's Net Cash Flow rose 12724.14% to $688603.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $81852.0, marking a year-over-year increase of 10090.02%. This contributed to the annual value of $81852.0 for FY2025, which is 10090.02% up from last year.
  • Latest data reveals that Aethlon Medical reported Net Cash Flow of $688603.0 as of Q1 2025, which was up 12724.14% from -$2.0 million recorded in Q4 2024.
  • In the past 5 years, Aethlon Medical's Net Cash Flow ranged from a high of $15.3 million in Q2 2021 and a low of -$3.3 million during Q1 2022
  • Its 5-year average for Net Cash Flow is -$386066.6, with a median of -$2.2 million in 2022.
  • As far as peak fluctuations go, Aethlon Medical's Net Cash Flow skyrocketed by 34051.58% in 2022, and later plummeted by 15810.79% in 2023.
  • Over the past 5 years, Aethlon Medical's Net Cash Flow (Quarter) stood at -$2.8 million in 2021, then grew by 24.56% to -$2.1 million in 2022, then fell by 4.99% to -$2.2 million in 2023, then increased by 8.57% to -$2.0 million in 2024, then surged by 134.09% to $688603.0 in 2025.
  • Its Net Cash Flow was $688603.0 in Q1 2025, compared to -$2.0 million in Q4 2024 and -$2.2 million in Q3 2024.